Literature DB >> 15958469

Medical treatment in head and neck cancer.

J B Vermorken1.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15958469     DOI： 10.1093/annonc/mdi735

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  14 in total

1.  The potential of helical tomotherapy in the treatment of head and neck cancer.

Authors:  Dirk Van Gestel; Dirk Verellen; Lien Van De Voorde; Bie de Ost; Geert De Kerf; Olivier Vanderveken; Carl Van Laer; Danielle Van den Weyngaert; Jan B Vermorken; Vincent Gregoire
Journal:  Oncologist       Date:  2013-05-30

Review 2.  [Photodynamic therapy using m-THPC (Foscan). Treatment of head and neck squamous cell carcinoma].

Authors:  R Naim
Journal:  HNO       Date:  2008-05       Impact factor: 1.284

Review 3.  Gemcitabine-Based Chemoradiation in the Treatment of Locally Advanced Head and Neck Cancer: Systematic Review of Literature and Meta-Analysis.

Authors:  Olivier M Vanderveken; Petr Szturz; Pol Specenier; Marco C Merlano; Marco Benasso; Dirk Van Gestel; Kristien Wouters; Carl Van Laer; Danielle Van den Weyngaert; Marc Peeters; Jan Vermorken
Journal:  Oncologist       Date:  2015-12-28

4.  Is there a patient population with squamous cell carcinoma of the head and neck region who might benefit from de-intensification of postoperative radiotherapy? : A monocentric retrospective analysis of a previously defined low-risk patient population treated with standard-of-care radiotherapy.

Authors:  Yonca Onbasi; Sebastian Lettmaier; Markus Hecht; Sabine Semrau; Heinrich Iro; Marco Kesting; Rainer Fietkau; Marlen Haderlein
Journal:  Strahlenther Onkol       Date:  2019-01-04       Impact factor: 3.621

5.  AXL Is a Logical Molecular Target in Head and Neck Squamous Cell Carcinoma.

Authors:  Toni M Brand; Mari Iida; Andrew P Stein; Kelsey L Corrigan; Cara M Braverman; John P Coan; Hannah E Pearson; Harsh Bahrar; Tyler L Fowler; Bryan P Bednarz; Sandeep Saha; David Yang; Parkash S Gill; Mark W Lingen; Vassiliki Saloura; Victoria M Villaflor; Ravi Salgia; Randall J Kimple; Deric L Wheeler
Journal:  Clin Cancer Res       Date:  2015-03-12       Impact factor: 12.531

6.  A non-randomized comparison of gemcitabine-based chemoradiation with or without induction chemotherapy for locally advanced squamous cell carcinoma of the head and neck.

Authors:  Pol M Specenier; Joost Weyler; Carl Van Laer; Danielle Van den Weyngaert; Jan Van den Brande; Manon T Huizing; Sevilay Altintas; Jan B Vermorken
Journal:  BMC Cancer       Date:  2009-08-06       Impact factor: 4.430

7.  Potential therapeutic strategy for oral squamous cell carcinoma by ErbB3-binding protein 1 gene transfer.

Authors:  Xu Zhou; Wantao Chen; Yuexing Zhang; Jian Sun; Qing Wang; Youcheng Yu
Journal:  J Cancer Res Clin Oncol       Date:  2009-11-24       Impact factor: 4.553

8.  Effects of paclitaxel on permanent head and neck squamous cell carcinoma cell lines and identification of anti-apoptotic caspase 9b.

Authors:  Regina Maushagen; Stefan Reers; Ann-Christin Pfannerstill; Angelina Hahlbrock; Roland Stauber; Ramtin Rahmanzadeh; Dirk Rades; Ralph Pries; Barbara Wollenberg
Journal:  J Cancer Res Clin Oncol       Date:  2016-04-01       Impact factor: 4.553

9.  A Preliminary Study of Serum Apelin Levels in Patients with Head and Neck Cancer.

Authors:  Meryem Aktan; Hilal Kiziltunc Ozmen
Journal:  Eurasian J Med       Date:  2019-02

10.  Cetuximab concomitant with second-line radiation therapy in patients with locally advanced recurrent squamous cell head and neck cancer.

Authors:  Muge Akmansu; Suleyman Buyukberber; Sevilay Iren; Umut Demirci; Gul Kanyilmaz; Ugur Coskun; Huseyin Bora
Journal:  Case Rep Oncol       Date:  2010-12-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.